Probability of overall survival after unrelated donor transplantations for Ph⁻ ALL in first CR. White blood cells at diagnosis (A), donor-recipient HLA-match (B), donor-recipient CMV status (C), time from diagnosis to complete remission (D), and GVHD prophylaxis (E).